Concepedia

Daniel Bauer

DB

23

Publications

1.2K

Citations

18

H-Index

1970

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

University of Göttingen

Novartis (United States)

Roche (Switzerland)

Daniel Bauer is an author at Novartis (Switzerland) specializing in medicine, photochemistry, and pharmacology.

ORCID

Top concepts

Publications per year

1970–2024

23

Publications

23

Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer

Matthew J. LaMarche, Michael Acker, Andreea Argintaru et al. · Journal of Medicinal Chemistry · 2020 · 207 citations · Full text

Functional Itch Disorder or Psychogenic Pruritus: Suggested Diagnosis Criteria From the French Psychodermatology Group

L Misery, Susana Alexandre, Sabine Dutray et al. · Acta Dermato Venereologica · 2007 · 115 citations · Full text

, , +13

Photobiocatalytic decarboxylation for olefin synthesis

Ioannis Zachos, Sarah Katharina Gaßmeyer, Daniel Bauer et al. · Chemical Communications · 2014 · 110 citations

Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers

Emilie A. Chapeau, Laurent Sansregret, Giorgio Giacomo Galli et al. · Nature Cancer · 2024 · 104 citations · Full text

The 3T3 neutral red uptake phototoxicity test: Practical experience and implications for phototoxicity testing – The report of an ECVAM–EFPIA workshop

Mara Ceridono, Pär Tellner, Daniel Bauer et al. · Regulatory Toxicology and Pharmacology · 2012 · 102 citations

, , +14

Rows per page

1–5 of 23